Breaking Finance News

A statement released earlier today by Brean Murray about Analogic Company (NASDAQ:ALOG) raises the target price to $100.00

Analogic Company (NASDAQ:ALOG) had its price target upped to $100.00 by Brean Murray in an issued report issued Thursday September 22, 2016. The bumped up target suggests a possible upside of 0.12% based on the company's previous stock price.

Just yesterday Analogic Company (NASDAQ:ALOG) traded -2.51% lower at $89.32. ALOG’s 50-day average is $88.68 and its two hundred day average is $82.43. With the last close up 8.36% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Trade Volume was up over the average, with 109,374 shares of ALOG changing hands over the typical 74,781

Recent Performance Chart

Analogic Company (NASDAQ:ALOG)

Analogic Company has PE ratio of 78.35 with a one year low of $68.71 and a one year high of $93.73 and has a market capitalization of $0.

A total of 3 brokerages have issued a research note on the company. One firm rating the stock a strong buy, one equity analyst rating the company a buy, 1 broker rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 equity analysts rating the company a sell with a one year target of $88.67.

More About Analogic Company (NASDAQ:ALOG)

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The Company operates through three business segments: Medical Imaging, Ultrasound, and Security and Detection. The Company's Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. Its Ultrasound segment provides ultrasound guidance systems for the urology and surgery markets and sells its ultrasound products, under the BK Ultrasound brand. The Company's Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.